Among the TRPM subfamily, TRPM1 was the first identified in melanoma and is associated with tumor progression and survival, potentially through CaMKII-mediated activation of AKT signaling, thereby enhancing colony formation and tumor growth [168,169]. Here, CAMK2G is linked to neoplasm.